Skip to main content
logo
C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
4.000
-0.030 (-0.74%)
At close: Aug 21, 2026, 4:00 PM EDT
4.051
+0.051 (1.28%)
After-hours: Aug 21, 2026, 7:55 PM EDT

C4 Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-101.42-104.99-105.32-132.49-128.18-83.89
Depreciation & Amortization
1.581.961.821.881.681.49
Other Amortization
---0.410.710.72
Asset Writedown & Restructuring Costs
10.7310.73-6.16--
Loss (Gain) From Sale of Investments
-2.65-2.74-5.4-3.780.711.88
Stock-Based Compensation
14.3119.129.6627.2430.0221.51
Other Operating Activities
6.116.536.430.75.91.42
Change in Accounts Receivable
0.870.78.7-10.334.24-1.23
Change in Accounts Payable
-1.09-0.47-0.120.27-3.33-1.18
Change in Unearned Revenue
-3.4-18.849.883.77-22.65-25.05
Change in Other Net Operating Assets
-9.91-10.68-10.81-0.664.96-2.63
Operating Cash Flow
-84.87-98.69-65.16-106.84-105.94-86.97
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.52-0.61-0.18-1.71-5.5-1.28
Investment in Securities
-74.79-7.99-51.09160.0663.92-188.06
Investing Cash Flow
-75.31-8.6-51.27158.3558.42-189.34

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----12.5--
Net Debt Issued (Repaid)
----12.5--
Issuance of Common Stock
160.65126.3245.1557.730.78183.1
Repurchase of Common Stock
-0.24-0.19-0.19-0.11--
Other Financing Activities
0.220.270.380.370.37-11.7
Financing Cash Flow
160.63126.445.3445.491.15171.4

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
0.4519.1-71.0997-46.37-104.9

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-85.39-99.3-65.34-108.55-111.44-88.24
Free Cash Flow Growth
------
Free Cash Flow Margin
-243.71%-276.24%-183.61%-522.96%-358.36%-192.73%
Free Cash Flow Per Share
-0.77-1.20-0.94-2.19-2.28-1.92
Levered Free Cash Flow
-43.66-54.3-35.43-66.06-62.78-30.22
Unlevered Free Cash Flow
-43.66-54.3-35.43-65.6-62.11-29.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---0.991.621.31
Cash Income Tax Paid
---1--
Change in Working Capital
-13.53-29.287.65-6.94-16.78-30.09
SEC Filings: 10-K · 10-Q